You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
濟南高新(600807.SH):實時熒光定量PCR分析儀獲批上市
格隆匯 07-05 16:55

格隆匯7月5日丨濟南高新(600807.SH)公佈,公司控股子公司近日艾克韋生物收到國家藥監局頒發的《醫療器械註冊證》。產品名稱:實時熒光定量PCR儀;註冊證編號:國械注準20223220773;適用範圍:與配套的核酸檢測試劑共同使用,在臨牀上可對來源於人體全血、血清/血漿、口咽拭子、痰液、糞便樣本中的靶核酸(DNA/RNA)進行定量、定性檢測,包括病原體和人類基因突變、分型項目;註冊證有效期:2022年6月27日-2027年6月26日。

艾克韋生物自主研發的實時熒光定量PCR分析儀,可與配套的核酸檢測試劑共同使用,能夠進行快速、準確的定量、定性檢測,應用範圍較為廣泛。該次醫療器械註冊證的取得,豐富了艾克韋生物產品線,有利於增強艾克韋生物的綜合競爭力和市場拓展能力,提升公司實業運營板塊核心競爭力,符合公司發展戰略。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account